FDA Puts Boxed Warnings on JAK Inhibitors Based on the safety review of tofacitinib in Pfizer's Oral Surveillance study, the FDA has formalized the recommendation that patients should be started on a TNF inhibitor (TNFi) before trying a JAK inhibitor. https://t.co/bXZ4Yedyyv https://t.co/tsvHOtIEK0